The start of the new year is typically a time when people make big changes around health—and drug companies are no exception. Pfizer alone is raising prices on over 60 drugs, the most on the list.

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.

Pfizer alone is raising prices on over 60 drugs, the most on the list. (Pfizer has nearly 500 products in its portfolio.) In addition to a 3% increase on Paxlovid, its COVID treatment, Pfizer’s ...

The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $32.15. PFE has been the subject of several analyst reports. Truist Financial ...

Sasanlimab, a subcutaneous immunotherapy developed by Pfizer, could help treat bladder cancer. Elsewhere, Royalty Pharma ...

The UK's competition watchdog has fined Pfizer ... the price of phenytoin sodium capsules in 2012 after “de-branding” the drug. The amount the NHS was charged for 100mg packs of the drug ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

operating in the sector and classified as a on the bse, currently has its share price at The stock has experienced fluctuations today, with a low of ₹ and a high of ₹ Over the past 52 weeks ...

A Aaaaa Aaaaaaa 195.59 +23.02% ...

Pfizer is facing a very different environment for the drug, as well as its COVID-19 vaccine, as the market transitions to a post-pandemic commercial model driven by health insurers. The price to ...